Table 2 |
|||||||
|
Relationship between MK-1 and RegIV expression and the clinical pathology characters of adenocarcinoma |
|||||||
|
Clinical Pathological Characters |
Number of cases |
MK-1 |
RegIV |
||||
|
|
|||||||
|
Positive cases (%) |
χ2 |
P |
Positive cases (%) |
χ2 |
P |
||
|
|
|||||||
|
Sex |
|||||||
|
Male |
24 |
16 (66.7) |
0.28 |
> 0.05 |
11 (45.8) |
0.77 |
> 0.05 |
|
Female |
84 |
51 (60.7) |
47 (56.0) |
||||
|
Age |
|||||||
|
≤ 45 yr |
31 |
19 (61.3) |
0.01 |
> 0.05 |
15 (48.4) |
0.49 |
> 0.05 |
|
> 45 yr |
77 |
48 (62.3) |
43 (55.8) |
||||
|
Pathological type |
|||||||
|
Highly differentiated |
36 |
29 (80.6) |
16.35 |
< 0.01 |
12 (33.3) |
9.94 |
< 0.05 |
|
Moderately differentiated |
31 |
20 (64.5) |
19 (61.3) |
||||
|
Low differentiated |
30 |
10 (33.3) |
21 (70.0) |
||||
|
Mucous adenocarcinoma |
11 |
8 (72.7) |
6 (54.5) |
||||
|
Maximal diameter |
|||||||
|
< 2 cm |
31 |
23 (74.2) |
2.73 |
> 0.05 |
13 (41.9) |
2.42 |
> 0.05 |
|
≥2 cm |
77 |
44 (57.1) |
45 (58.4) |
||||
|
Lymphatic metastasis |
|||||||
|
None |
49 |
39 (79.6) |
11.74 |
< 0.05 |
20 (40.8) |
4.24 |
< 0.05 |
|
Yes |
59 |
28 (47.6) |
38 (64.4) |
||||
|
Peritissue invasion |
|||||||
|
None |
49 |
37 (75.5) |
6.91 |
< 0.05 |
21 (42.9) |
4.24 |
< 0.05 |
|
Yes |
59 |
30 (50.9) |
37 (62.7) |
||||
|
Cholecystolithiasis |
|||||||
|
None |
50 |
28 (56.0) |
1.44 |
> 0.05 |
24 (48.0) |
1.22 |
> 0.05 |
|
Yes |
58 |
39 (67.2) |
34 (58.6) |
||||
|
|
|||||||
|
Yang et al. Diagnostic Pathology 2011 6:100 doi:10.1186/1746-1596-6-100 |
|||||||
